MACHINE LEARNING-BASED EXPLANATION OF RACIAL-ETHNIC DISPARITIES IN 5-YEAR CANCER-SPECIFIC SURVIVAL AMONG HORMONE RECEPTOR-POSITIVE BREAST CANCER PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Harun, R. [1 ]
Kim, E. [2 ]
Cheng, A. [2 ]
Abbass, I [2 ]
机构：
[1] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO65
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [11] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Megan C. Roberts
    Dave P. Miller
    Steven Shak
    Valentina I. Petkov
    Breast Cancer Research and Treatment, 2017, 163 : 303 - 310
  • [12] Effect of Surgery on Breast Cancer-Specific Mortality in Elderly Patients with Hormone Receptor-Positive, HER2Negative Breast Cancer
    Yatsuyanagi, Misako
    Shimada, Tomoyuki
    Takeishi, Yuko
    Matsuzaka, Yukiko
    Ohsawa, Chika
    CANCER RESEARCH, 2024, 84 (09)
  • [13] A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer
    Stabellini, Nickolas
    Makram, Omar M.
    Kunhiraman, Harikrishnan Hyma
    Daoud, Hisham
    Shanahan, John
    Montero, Alberto J.
    Blumenthal, Roger S.
    Aggarwal, Charu
    Swami, Umang
    Virani, Salim S.
    Noronha, Vanita
    Agarwal, Neeraj
    Dent, Susan
    Guha, Avirup
    JNCI CANCER SPECTRUM, 2025, 9 (01)
  • [14] Racial/ethnic differences in 21-gene recurrence score and survival among estrogen receptor-positive breast cancer patients.
    Gill, Jasmin
    Ma, Sung Jun
    Yendamuri, Keerti
    Chatterjee, Udit
    Yao, Song
    Oladeru, Oluwadamilola Temilade
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [15] Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer
    Sendur, M. A. N.
    Aksoy, S.
    Zengin, N.
    Altundag, K.
    JOURNAL OF BUON, 2013, 18 (04): : 838 - 844
  • [16] Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer
    Zhu, Jingjing
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Yu, Kaijie
    Wu, Lunpo
    Li, Dan
    Zhou, Shishi
    Tang, Wanfen
    Wang, Qinghua
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Du, Jinlin
    Fu, Jianfei
    CLINICAL BREAST CANCER, 2022, 22 (03) : E296 - E309
  • [17] Competing nomogram for late-period breast cancer-specific death in patients with early-stage hormone receptor-positive breast cancer
    Fu, J.
    Li, D.
    Wu, L.
    Yu, K.
    Du, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [18] Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer A Post Hoc Analysis of the TAILORx Randomized Clinical Trial
    Kantor, Olga
    King, Tari A.
    Freedman, Rachel A.
    Mayer, Erica L.
    Chavez-MacGregor, Mariana
    Korde, Larissa A.
    Sparano, Joseph A.
    Mittendorf, Elizabeth A.
    JAMA SURGERY, 2023, 158 (06) : 583 - 591
  • [19] Racial/ethnic difference in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer
    Farias, Albert
    Du, Xianglin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [20] Development of a Machine Learning-Based Prognostic Model for Hormone Receptor-Positive Breast Cancer Using Nine-Gene Expression Signature
    Takeshita, Takashi
    Iwase, Hirotaka
    Wu, Rongrong
    Ziazadeh, Danya
    Yan, Li
    Takabe, Kazuaki
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (05) : 406 - 422
12345